Marker Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.928; its P/E ratio is -2.28; Marker Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 1.06M	$ 762.66K	-	$ 3.31M	$ 2.95M
Gross Profit	$ 1.06M	$ 762.66K	-	-	-
EBIT	$ -2.74M	$ -4.10M	$ -4.97M	$ -2.10M	$ -7.02M
EBITDA	$ -2.74M	$ -5.07M	$ -4.00M	$ -1.13M	$ -5.98M
Net Income Common Stockholders	$ -2.80M	$ 9.13M	$ -4.97M	$ -2.10M	$ -6.92M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 15.10M	$ 18.10M	$ 6.40M	$ 11.78M	$ 18.08M
Total Assets	$ 17.13M	$ 21.96M	$ 27.91M	$ 34.42M	$ 41.11M
Total Debt	$ 0.00	$ 0.00	$ 7.49M	$ 7.62M	$ 7.72M
Net Debt	$ -15.10M	$ -18.10M	$ 1.09M	$ -4.17M	$ -10.36M
Total Liabilities	$ 3.07M	$ 2.92M	$ 12.03M	$ 14.82M	$ 18.51M
Stockholders Equity	$ 14.05M	$ 19.03M	$ 15.91M	$ 19.60M	$ 22.60M
Cash Flow	-
Free Cash Flow	$ -2.37M	$ -7.06M	$ -5.89M	$ -6.31M	$ -7.75M
Operating Cash Flow	$ -2.37M	$ -7.06M	$ -5.89M	$ -6.31M	$ -7.65M
Investing Cash Flow	-	$ 18.78M	$ -112.61K	$ -127.34K	$ -99.37K
Financing Cash Flow	$ 5.13K	$ 736.00	$ 619.97K	$ 138.56K	$ 0.00

Currency in USD

Marker Therapeutics Earnings and Revenue History

Income Statement >

Marker Therapeutics Debt to Assets

Balance Sheet >

Marker Therapeutics Cash Flow

Cash Flow >

Marker Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing